Empire Financial Management Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
15,939
+244
| +2% | +$29.5K | 0.56% | 54 |
|
|
2025
Q1 | $1.75M | Buy |
15,695
+422
| +3% | +$47K | 0.54% | 62 |
|
|
2024
Q4 | $1.49M | Buy |
15,273
+899
| +6% | +$87.5K | 0.46% | 67 |
|
|
2024
Q3 | $1.65M | Sell |
14,374
-454
| -3% | -$52.2K | 0.51% | 64 |
|
|
2024
Q2 | $1.58M | Buy |
14,828
+167
| +1% | +$17.8K | 0.52% | 64 |
|
|
2024
Q1 | $1.42M | Buy |
14,661
+4,595
| +46% | +$444K | 0.47% | 67 |
|
|
2023
Q4 | $1.02M | Buy |
10,066
+81
| +0.8% | +$8.18K | 0.4% | 68 |
|
|
2023
Q3 | $1.02M | Sell |
9,985
-127
| -1% | -$12.9K | 0.44% | 66 |
|
|
2023
Q2 | $1.02M | Sell |
10,112
-373
| -4% | -$37.6K | 0.41% | 67 |
|
|
2023
Q1 | $965K | Buy |
+10,485
| New | +$965K | 0.39% | 73 |
|